In a significant announcement, President Trump is set to reveal a new drug pricing deal with AstraZeneca, following a similar agreement with Pfizer. This move aims to lower U.S. drug prices and pressure major drugmakers to bring manufacturing back to America. Will it lead to real savings for taxpayers?
As Trump's tariffs hit Switzerland with a staggering 39%, the Swiss economy faces serious consequences. With key industries at risk and potential job losses looming, how will Switzerland navigate the trade turmoil?
Singapore's pharmaceutical companies are anxious about new U.S. tariffs on branded drugs. Deputy PM Gan Kim Yong seeks clarity on tariff exemptions as firms plan U.S. expansions. Can they remain competitive?
In a surprising announcement, President Trump declared a 100% tariff on patented pharmaceuticals unless companies manufacture in the U.S., leaving many confused about the implications for drug prices and healthcare.
European stocks defy U.S. tariffs imposed by President Trump on pharmaceuticals and other sectors, indicating optimism in the market. As Wall Street treads carefully ahead of inflation data, analysts reflect on the impact of robust U.S. economic indicators.
GSK announces a groundbreaking $30 billion investment in the U.S. as President Trump visits the U.K. This commitment aims to enhance biopharma manufacturing and research, promising advancements in drug discovery and healthcare innovation.
Eli Lilly announces a groundbreaking $5 billion investment in a new manufacturing plant near Richmond, aimed at boosting U.S. production of essential pharmaceutical ingredients.
In a surprising turn, President Trump has retracted his plans for exorbitant tariffs on pharmaceuticals and semiconductors from the EU, capping them at 15%. This agreement, reached after intense negotiations, aims to stabilize trade relations and reduce costs for consumers and businesses.
Discover the key elements of President Trump's new trade deal with the EU, including significant changes to tariffs on cars, pharmaceuticals, and more. Find out how this will affect trade relations and investments!
The White House unveils a $550 billion investment agreement with Japan, promising strategic investments in key sectors. But experts raise doubts about its feasibility amidst ongoing tariff controversies.
